Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives

Published:2022-05 Issue: Volume:106 Page:102395
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Nicolò Eleonora,Giugliano Federica,Ascione Liliana,Tarantino Paolo,Corti Chiara,Tolaney Sara M.,Cristofanilli Massimo,Curigliano Giuseppe

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference100 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. Unlocking the potential of antibody–drug conjugates for cancer therapy;Drago;Nat Rev Clin Oncol,2021

3. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer;Verma;N Engl J Med,2012

4. Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies;Tarantino;CA Cancer J Clin,2022

5. A decade of immune-checkpoint inhibitors in cancer therapy;Robert;Nat Commun,2020

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions;Cancer Letters;2024-11

2. Synergistic Chemo-Immunotherapy: Recombinant Fusion Protein-Based Surface Modification of NK Cell for Targeted Cancer Treatment;Pharmaceutics;2024-09-08

3. Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer;Cancers;2024-09-04

4. Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil;Cancers;2024-09-03

5. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3